Kun Pang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Gut microbiota and health 4
- RNA modifications and cancer 4
- Single-cell and spatial transcriptomics 3
- Co-authors
- Zhenduo Shi (25 shared papers)Conghui Han (25 shared papers)Zhe‐Sheng Chen (6 shared papers)Jiaxin Qin (5 shared papers)Zhuo‐Xun Wu (3 shared papers)Dong Yang (2 shared papers)Lin Hao (19 shared papers)Guangyue Wang (4 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Lasers in Medical Science (2 papers)Journal of Asian Natural Products Research (2 papers)Recent Patents on Anti-Cancer Drug Discovery (2 papers)Signal Transduction and Targeted Therapy (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Kun Pang
52 papers receiving 1.2k citations
Kun Pang's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 172
- Oncology 194
- Molecular Biology 521
- Nephrology 39
- Immunology 116
Countries citing papers authored by Kun Pang
This map shows the geographic impact of Kun Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Pang more than expected).
Fields of papers citing papers by Kun Pang
This network shows the impact of papers produced by Kun Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Pang. The network helps show where Kun Pang may publish in the future.
Co-authors
The 25 scholars most cited alongside Kun Pang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade Hit paper breakdown → | 2022 | 174 |
| 2 | Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies Hit paper breakdown → | 2023 | 141 |
| 3 | 2022 | 87 | |
| 4 | 2022 | 85 | |
| 5 | 2022 | 84 | |
| 6 | 2019 | 63 | |
| 7 | 2021 | 45 | |
| 8 | 2021 | 44 | |
| 9 | 2022 | 36 | |
| 10 | 2021 | 31 | |
| 11 | 2022 | 29 | |
| 12 | 2021 | 28 | |
| 13 | 2023 | 27 | |
| 14 | 2019 | 26 | |
| 15 | 2025 | 24 | |
| 16 | 2022 | 24 | |
| 17 | 2020 | 21 | |
| 18 | 2024 | 20 | |
| 19 | 2013 | 20 | |
| 20 | 2020 | 18 |
About Kun Pang
Kun Pang is a scholar working on Molecular Biology, Cancer Research, Urology, Surgery and Pulmonary and Respiratory Medicine, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (5 papers), Hormonal and reproductive studies (4 papers), Gut microbiota and health (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Sexual function and dysfunction studies (4 papers), RNA modifications and cancer (4 papers), Urologic and reproductive health conditions (3 papers) and Single-cell and spatial transcriptomics (3 papers). The work is most often cited by research in Cancer Research (172 citations), Oncology (194 citations), Molecular Biology (521 citations), Nephrology (39 citations) and Immunology (116 citations). Kun Pang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Zhenduo Shi, Conghui Han, Zhe‐Sheng Chen, Jiaxin Qin, Zhuo‐Xun Wu, Dong Yang, Lin Hao, Guangyue Wang, Wei Wang and Zhongya Zhang. Their work appears in journals such as Frontiers in Oncology, Lasers in Medical Science, Journal of Asian Natural Products Research, Recent Patents on Anti-Cancer Drug Discovery and Signal Transduction and Targeted Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.